| Call 2014/2015 subtopics:

3.3 Drug discovery for cancer, cardiovascular and infectious diseases

Top causes of mortality (excluding incidents) worldwide are cardiovascular diseases, cancer and infectious diseases. The need for new principally novel drugs for treatment of these diseases is hard to overestimate. The main efforts should be invested into identification and study of drug targets, rational design and high throughput screening of potential drug candidates (leads). In this area there are many possibilities for successful scientific collaboration between EU and Russia.

The understanding of specific molecular mechanisms/pathways underlying particular disease initiation and progression, treatment resistance, etc. offers possibilities to identify relevant biomarkers, promising targets for new drug development. The evaluation and validation of such biomarkers using the state-of-the-art technologies, the development of relevant experimental scientific models, and the collaboration with biobank teams will be encouraged.

Documents

Contact

  • Dr Andreas Kahle

    • Senior Scientific Officer
      DLR Project Management Agency
      European and International Cooperation
    • Heinrich-Konen-Str. 1
    • D-53227 Bonn Germany
    • Telephone: +49 228 3821 1829
    • Fax: +49 228 3821 1400
    • Email Address: Andreas.Kahle@dlr.de
  • Nina Schüle

    • Senior Administrative Officer
      DLR Project Management Agency
      European and International Cooperation
    • Heinrich-Konen-Str. 1
    • 53227 Bonn | Germany
    • Telephone: +49 228 3821 1889
    • Fax: +49 228 3821 1444
    • Email Address: Nina.Schuele@dlr.de